Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice

Journal of Clinical Investigation

Volumn 107, Issue 4, 2001, Pages 439-447

  Sass, G ^a   Koerber, K ^a   Bang, R ^a   Guehring, H ^a   Tiegs, G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HISTOPATHOLOGY; LIVER INJURY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035110655     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10613     Document Type: Article

References (60)

1. Cytokines in viral hepatitis
2. Pathogenesis of autoimmune hepatitis
3. Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins
4. A T-cell dependent experimental liver injury in mice inducible by concanavalin A
5. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6
6. Concanavalin A-induced T cell-mediated hepatic injury in mice: The role of tumor necrosis factor
7. Interferon-γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A
8. Critical involvement of interferon γ in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis
9. In vivo evidence for a functional role of both TNF receptors and transmembrane TNF in experimental hepatitis
10. Involvement of 26-kDa cell-associated TNFα in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor
11. Disparate roles for TNF-α and Fas ligand in concanavalin A-induced hepatitis
12. Inducible nitric oxide synthase in the liver: Regulation and function
13. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
14. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?
15. Nitric oxide synthases: Which, where, how and why?
16. Inducible nitric oxide synthase: What difference does it make?
17. Nitric oxide in excitable tissues: Physiological roles and diseases
18. Cellular and molecular mechanisms of endothelial cell dysfunction
19. Nitric oxide and macrophage function
20. Mechanisms of nitric oxide-related antimicrobial activity
21. Inflammation, immunoregulation, and inducible nitric oxide synthase
22. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock
23. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease
24. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression
25. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice
26. Nitric oxide production in experimental alcoholic liver disease in the rat: Role in protection from injury
27. Interleukin-1 and nitric oxide protect against tumor necrosis factor α-induced liver injury through distinct pathways
28. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver
29. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon terrachloride
30. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock
31. Beneficial effects of inducible nitric oxide synthase inhibitor on reper fusion injury in the pig liver
32. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase
33. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model
34. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
35. 6-(1-iminoethyl)-lysine: A selective inhibitor of inducible nitric oxide synthase
36. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and tumor necrosis factor
37. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors
38. Importance of Kupffer cells for T cell-dependent liver injury in mice
39. Dexamethasone differentially affects interleukin 1β- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells
40. T cell-mediated experimental liver injury
41. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in the liver
42. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin
43. Interferon γ receptor deficient mice are resistant to endotoxic shock
44. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages
45. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis
46. Peroxinitrite formation during rat hepatic allograft rejection
47. Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis
48. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors
49. Nitric oxide prevents IL-1β and IFNγ-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1β-converting enzyme)
50. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis
51. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: The cytokine milieu of concanavalin A hepatitis
52. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model
53. Synergism of Pseudomonas aeruginosa exotoxin A with endotoxin, superantigen, or TNF results in TNFR1- and TNFR2-dependent liver toxicity in mice
54. Inducible NO synthase: Role in cellular signaling
55. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells
56. Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor-α synthesis
57. Staphylococcal enterotoxin A acts through nitric oxide synthase mechanisms in human peripheral blood mononuclear cells to stimulate synthesis of pyrogenic cytokines
58. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7
59. Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury